Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-B )

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorYongjun Wang

About this trial

To compare the door-to-puncture time of patients with hyperacute ischemic stroke (between 4.5-6 hours after the onset of symptoms) treated in a standard stroke unit adherent to guidelines versus treated in Emergency Stroke Unit (a new stroke unit based on low-field magnetic resonance imaging).

Eligibility criteria

Qualifiers

Age ≥ 18 years;

Can be treated between 4.5-6 hours of symptoms onset*(*Symptom onset is defined by the "last seen normal" principle);

Presenting with ischemic stroke symptoms;

Pre-stroke mRS score 0-1;

Disqualifiers

Baseline NIHSS score < 5;

Unable to undergo MRI because of claustrophobia;

Patients with cardiac pacemaker/brain pacemaker/insulin pump implantation;

Definite contraindication for endovascular thrombectomy;

Trial design

Treatments tested in this trial

  • Emergency Stroke Unit based on 0.23-T MRI
  • Standard stroke unit adherent to guidelines

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Yongjun Wang

Lead sponsor

Beijing Tiantan Hospital

Sponsor institution